AutoMynd
- Company typePrivate
- Founded2023
- HeadquartersWashington, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
AutoMynd firmographics
Firmographics- Name
- AutoMynd
- Legal name
- AutoMynd
- Website
- https://automynd.com
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Where AutoMynd is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Markets served
AutoMynd business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- AI Platform SaaS Subscription: AutoMynd operates primarily as a SaaS platform subscription model, offering access to its AI orchestration suite (Copilot, IntakeIQ, QAgent, Martha, MyndSight) on a per-agency, per-seat, or volume-based subscription basis. Pricing is quote-based, reflecting enterprise-level contracts tailored to agency size and module selection.
- API & Integration Licensing: Revenue from software partners embedding AutoMynd's API-first AI capabilities into their own EMR or health tech platforms. This includes white-label opportunities and workflow embedding licensing, generating recurring API usage fees or per-transaction licensing revenue.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise multi-module AI platform — full suite |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
AutoMynd product offering
Product offeringCore offering
AutoMynd is an AI-native platform that automates the home-based care workflow from referral intake through clinical documentation, QA, coding review, and analytics. It bundles ambient AI speech-to-text (Copilot), AI referral management (IntakeIQ), agentic chart review (QAgent), a pre-visit voice assistant (Martha), and visit-level analytics (MyndSight) into a single subscription sold to home health, hospice, home care, health plan, and software partner customers.
Product overview
AutoMynd is an AI-native platform for post-acute care providers that delivers an integrated suite of AI-powered solutions spanning from intake to documentation to quality assurance. The platform consists of six core products: IntakeIQ (AI-powered referral management), Martha (pre-visit voice assistant), Copilot (ambient AI clinical documentation), QAgent (AI-guided chart review), MyndSight (clinical compliance and analytics), and Patient360 (patient engagement). These products work together as a unified system of action, connecting the full care journey from referral intake through clinical documentation, QA, coding review, patient engagement, and reimbursement. The platform orchestrates AI where it truly matters in home-based care workflows.
Differentiator
Problem solved
Functional benefit
Brands
- IntakeIQ: AI-powered referral and intake platform that speeds admissions for home-based care
- Copilot
- QAgent
- Martha
- MyndSight
Products and services
- Copilot
Quantifiable outcome
- 66% reduction in documentation time (from 3 hours to ~1 hour per client) for personal care agencies
- +7 more outcomes
Companies that use AutoMynd
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
AutoMynd technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability12 records
Feature6 records
AutoMynd partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- WellSkycoreWellSky and AutoMynd co-developed WellSky Ambient Documentation for Personal Care — the first ambient AI documentation solution specifically for personal care agencies. The product automates assessment and care plan documentation, with early adopters reporting a 66% reduction in documentation time. Scheduled for a May 2026 launch. This partnership positions AutoMynd's AI inside WellSky's extensive post-acute care software ecosystem, expanding reach to WellSky's customer base of personal care agencies.
- Butte Home Health & HospiceflagshipButte Home Health & Hospice partnered with AutoMynd to deploy ambient AI documentation, OASIS automation, IntakeIQ, and QAgent across their clinical and back-office operations. The collaboration enables faster documentation, streamlined intake, improved QA accuracy, and a more efficient experience for both clinicians and patients. Butte Home Health & Hospice is described as 'raising the bar for both patient and clinician experience' by deploying AutoMynd's AI platform.
- Ohioans Home HealthcareflagshipOhioans Home Healthcare, recognized for delivering high-quality, patient-centered home health services, partnered with AutoMynd to deploy Copilot, IntakeIQ, and QAgent across its clinical and back-office workflows. The partnership has been active since April 2025, delivering measurable outcomes including reduced after-hours charting, improved OASIS-E accuracy, faster billing, and improved QA processes. Described by AutoMynd CEO as a 'real partnership' driving meaningful change in home health.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
AutoMynd competitors and assessment
Company assessmentDirect peers
- Suki AI: AI-powered ambient clinical documentation and voice assistant for clinicians. Direct competitor to AutoMynd's Copilot product, operating across ambulatory and acute settings with similar ambient-documentation, EHR-embed, and subscription SaaS model.
- Abridge: Ambient AI platform that generates clinical notes from patient-provider conversations and integrates with EHRs. Direct competitor in ambient documentation; AutoMynd's Copilot and MyndSight compete head-to-head with Abridge's note generation and analytics.
- DeepScribe: AI medical scribe that automates clinical documentation and integrates with EHR systems. Closely comparable to AutoMynd's Copilot in product mechanics (ambient capture, structured note generation, EHR integration) and target buyers (clinicians/medical groups).
- Augmedix: Ambient medical documentation and clinical data services, including a fully automated AI scribe product. Comparable to AutoMynd in automating clinician documentation and serving enterprise health systems, though Augmedix has historically emphasized remote human-in-the-loop scribing alongside AI.
- Notable: AI platform for ambient clinical documentation, patient intake, and workflow automation across health systems. Comparable to AutoMynd in offering an end-to-end ambient platform that goes beyond notes into intake and workflow automation.
Broad incumbents
- Nuance DAX (Microsoft): Microsoft-owned Dragon Ambient eXperience (DAX) for clinical documentation. Larger, broad-incumbent competitor with ambient AI notes, deep Epic/Cerner integration, and enterprise health system footprint that can encroach on AutoMynd's enterprise buyers.
- MModal (3M Health Information Systems): Established clinical documentation and speech recognition vendor (formerly MModal, now part of 3M/HIS). Broad-incumbent competitor with similar ambient/speech-to-text, coding, and QA workflow offerings sold to large healthcare enterprises.
Emerging players
- Athelas (Commure): Healthcare AI platform company (Commure, following Athelas's expansion) building ambient documentation, revenue cycle, and workflow tools. Emerging player with overlap in ambient AI documentation and a broader healthcare AI suite.
- Tali AI: AI medical scribe and ambient documentation assistant for clinicians and EHRs. Emerging competitor with similar speech-to-text, EHR integration, and clinician-productivity thesis, though smaller scale than AutoMynd's enterprise deployments.
Others
- WellSky: Major post-acute / home-health software platform and AutoMynd's anchor strategic partner (co-developing WellSky Ambient Documentation for Personal Care). Included as a peer given its central role in AutoMynd's distribution and as a potential future competitor that could internalize ambient AI.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
AutoMynd social profiles
Digital presenceAutoMynd compliance and trust
Trust signalCompliance2 records
AutoMynd financial estimates
Financial estimateRevenue estimate
Valuation estimate
AutoMynd leadership team
Management profileNumber of profiles
Profiles9 records
AutoMynd funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AutoMynd M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AutoMynd
What does AutoMynd do?
AutoMynd is an AI-native platform that automates the home-based care workflow from referral intake through clinical documentation, QA, coding review, and analytics. It bundles ambient AI speech-to-text (Copilot), AI referral management (IntakeIQ), agentic chart review (QAgent), a pre-visit voice assistant (Martha), and visit-level analytics (MyndSight) into a single subscription sold to home health, hospice, home care, health plan, and software partner customers.
When was AutoMynd founded?
AutoMynd was founded in 2023. It employs 1 to 10 people.
Where is AutoMynd based?
AutoMynd is headquartered in Washington, United States, in the North America region.
How does AutoMynd make money?
Two revenue lines are on record. AI Platform SaaS Subscription is the primary driver. The others are API & Integration Licensing.
Who are AutoMynd's main competitors?
Direct peers on record are Suki AI, Abridge, DeepScribe, Augmedix and Notable. Broad incumbents are Nuance DAX (Microsoft) and MModal (3M Health Information Systems). Emerging players are Athelas (Commure) and Tali AI. WellSky is listed as an others.
Does AutoMynd have an API?
Yes. AutoMynd offers an API-first AI platform that enables software partners to embed ambient intelligence into their EMR or health tech platforms. The developer-friendly stack supports fast-track integration with flexible, well-documented APIs. Partners can add clinical documentation, intake, and QA directly into their applications with white-label opportunities available.